Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Application of spectroscopic imaging for characterizing API: polymer systems as a screening tool for the development of potential amorphous solid dispersions

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11160%2F17%3A10374955" target="_blank" >RIV/00216208:11160/17:10374955 - isvavai.cz</a>

  • Výsledek na webu

    <a href="http://www.ptfarm.pl/wydawnictwa/czasopisma/acta-poloniae-pharmaceutica/110/-/27117" target="_blank" >http://www.ptfarm.pl/wydawnictwa/czasopisma/acta-poloniae-pharmaceutica/110/-/27117</a>

  • DOI - Digital Object Identifier

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Application of spectroscopic imaging for characterizing API: polymer systems as a screening tool for the development of potential amorphous solid dispersions

  • Popis výsledku v původním jazyce

    Raman and infrared mapping techniques were employed in this study for the characterization of drug-polymer films cast on glass plates and for finding good amorphous solid dispersion formulation candidates containing dabigatran etexilate. To verify the results obtained from this approach, two common solvent evaporation-based solid dispersion processes were used for the preparation of samples and those samples were analyzed conventionally, with solid state NMR and modulated DSC. Solid solutions containing amorphous dabigatran etexilate with a low probability of crystallization were identified, using mapping techniques in samples with 75% of drug dissolved in Kollidon K30 and in 50% of drug dissolved in Kollidon VA64 and Soluplus. On the contrary, all samples prepared by spray drying were characterized as solid solutions which may lead to crystallization of the API in certain concentrations. This was shown to be valid in materials containing Kollidon VA64 and Soluplus, respectively, and more than 50% of the API when prepared by solvent evaporation. The experimental data obtained in this study proved that spectral mapping-based screening methods are able to identify potential candidates for amorphous solid dispersion formulations which are less prone to crystallization.

  • Název v anglickém jazyce

    Application of spectroscopic imaging for characterizing API: polymer systems as a screening tool for the development of potential amorphous solid dispersions

  • Popis výsledku anglicky

    Raman and infrared mapping techniques were employed in this study for the characterization of drug-polymer films cast on glass plates and for finding good amorphous solid dispersion formulation candidates containing dabigatran etexilate. To verify the results obtained from this approach, two common solvent evaporation-based solid dispersion processes were used for the preparation of samples and those samples were analyzed conventionally, with solid state NMR and modulated DSC. Solid solutions containing amorphous dabigatran etexilate with a low probability of crystallization were identified, using mapping techniques in samples with 75% of drug dissolved in Kollidon K30 and in 50% of drug dissolved in Kollidon VA64 and Soluplus. On the contrary, all samples prepared by spray drying were characterized as solid solutions which may lead to crystallization of the API in certain concentrations. This was shown to be valid in materials containing Kollidon VA64 and Soluplus, respectively, and more than 50% of the API when prepared by solvent evaporation. The experimental data obtained in this study proved that spectral mapping-based screening methods are able to identify potential candidates for amorphous solid dispersion formulations which are less prone to crystallization.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    30104 - Pharmacology and pharmacy

Návaznosti výsledku

  • Projekt

  • Návaznosti

    S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2017

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Acta Poloniae Pharmaceutica

  • ISSN

    0001-6837

  • e-ISSN

  • Svazek periodika

    74

  • Číslo periodika v rámci svazku

    6

  • Stát vydavatele periodika

    PL - Polská republika

  • Počet stran výsledku

    8

  • Strana od-do

    1851-1858

  • Kód UT WoS článku

    000430449500025

  • EID výsledku v databázi Scopus

    2-s2.0-85037704499